Currently Viewing:
ADA 2013
NOW AVAILABLE: ADA 2013 Conference Coverage
August 16, 2013
Impact of Quality Care Measures on Patient Care
June 25, 2013
Non-Glycemic Effects of Glucagon-Like Peptide-1 Agonists and Dipeptidyl Peptidase-4 Inhibitors
June 25, 2013
Pharmacotherapy for Obesity: Filling a Therapeutic Gap
June 25, 2013
Ronald J. Sigal, MD, MPH, Discusses the Reality of Exercise and Physical Activity Goals for Most Patients
June 24, 2013
Philip R. Schauer, MD, Shares His Thoughts on the Necessary Direction of Accountable Care Organizations
June 24, 2013
Diabetes Coaching Services in the Pharmacy Setting
June 24, 2013
Currently Reading
Todd Brusko, PhD, Remarks on Evolving Role of Immunoregulation in Type 1 Diabetes
June 24, 2013
Novel SGLT-2 Inhibitors: The Impact on Outcomes in Diabetes and Cardiovascular Health
June 23, 2013
Connecting the Dots: Global Epidemiology of Type 1 Diabetes and National Income Levels
June 23, 2013
Sheldon Greenfield, MD, Discusses Integrating Quality Care Measures into Diabetes Management: Two Sides of the Coin
June 23, 2013
Rita Basu, MD, Discusses The Role of Testosterone Supplementation in Men with Diabetes
June 23, 2013
Diabetes Cost-Effectiveness Studies and How They Affect Real-World Treatment
June 22, 2013
Sandeep Dhindsa, MD:The Chicken or the Egg: Which Comes First, Diabetes or Low Testosterone in Men?
June 22, 2013
Andrew J. Palmer, MD: Allocating Resources Effectively for Patients in the United States and Around the World
June 22, 2013
Jaakko Tuomilehto, MD, PhD, Discusses The Link Between Type 1 Diabetes Mellitus and a Nation's Socioeconomic Status
June 22, 2013

Todd Brusko, PhD, Remarks on Evolving Role of Immunoregulation in Type 1 Diabetes

Todd Brusko, PhD, of the Todd M. Brusko Laboratory at the University of Florida College of Medicine, discussed how knowledge of regulatory T-cells has grown and improved, and noted that research has now entered a phase of harnessing the potential of our immune system through specific cell populations to combat root causes of type 1 diabetes (T1DM).


Todd Brusko, PhD, of the Todd M. Brusko Laboratory at the University of Florida College of Medicine, discussed how knowledge of regulatory T-cells has grown and improved, and noted that research has now entered a phase of harnessing the potential of our immune system through specific cell populations to combat root causes of type 1 diabetes (T1DM).

This video was taken at the  American Diabetes Associations 73rd Scientific Sessions in Chicago, IL.
American Diabetes Associations
American Diabetes Associations
  - See more at: http://www.ajmc.com/conferences/ada-2013/The-Chicken-or-the-Egg-Which-Comes-First-Diabetes-or-Low-Testosterone-in-Men-#sthash.pQwMgOSo.dpuf
This video was taken at the  American Diabetes Associations 73rd Scientific Sessions in Chicago, IL.

 
Copyright AJMC 2006-2017 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!